Why is Globus Medical, Inc. ?
1
Company has a low Debt to Equity ratio (avg) at times
2
Low Debt Company with Strong Long Term Fundamental Strength
3
The company has declared Positive results for the last 3 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 669.15 MM
- NET PROFIT(Q) Highest at USD 252.97 MM
- RAW MATERIAL COST(Y) Fallen by -16.19% (YoY)
4
With ROE of 5.54%, it has a expensive valuation with a 1.98 Price to Book Value
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 7.16%, its profits have risen by 69.2% ; the PEG ratio of the company is 0.5
How much should you buy?
- Overall Portfolio exposure to Globus Medical, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Globus Medical, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Globus Medical, Inc.
20.72%
0.64
53.51%
S&P 500
18.81%
0.70
20.15%
Quality key factors
Factor
Value
Sales Growth (5y)
29.27%
EBIT Growth (5y)
27.88%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.11
Sales to Capital Employed (avg)
0.51
Tax Ratio
20.34%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
12.35%
ROE (avg)
7.98%
Valuation Key Factors 
Factor
Value
P/E Ratio
23
Industry P/E
Price to Book Value
2.63
EV to EBIT
24.97
EV to EBITDA
15.46
EV to Capital Employed
2.79
EV to Sales
4.05
PEG Ratio
0.09
Dividend Yield
NA
ROCE (Latest)
11.16%
ROE (Latest)
11.41%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
No Trend
Bullish
OBV
No Trend
Mildly Bearish
Technical Movement
21What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 715.2 MM
NET PROFIT(HY)
Higher at USD 369.72 MM
ROCE(HY)
Highest at 10.01%
OPERATING PROFIT(Q)
Highest at USD 205.81 MM
RAW MATERIAL COST(Y)
Fallen by -22.21% (YoY
NET SALES(Q)
Highest at USD 769.05 MM
-3What is not working for the Company
CASH AND EQV(HY)
Lowest at USD 619.97 MM
Here's what is working for Globus Medical, Inc.
Net Profit
At USD 369.72 MM has Grown at 292.93%
Year on Year (YoY)MOJO Watch
Net Profit trend is very positive
Net Profit (USD MM)
Operating Cash Flow
Highest at USD 715.2 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Operating Profit
Highest at USD 205.81 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Operating Profit trend is quite positive
Operating Profit (USD MM)
Net Profit
Higher at USD 369.72 MM
than preceding 12 month period ended Sep 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Net Sales
Highest at USD 769.05 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Net Sales
At USD 769.05 MM has Grown at 17.12%
over average net sales of the previous four periods of USD 656.62 MMMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Raw Material Cost
Fallen by -22.21% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at USD 71.13 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Here's what is not working for Globus Medical, Inc.
Cash and Eqv
Lowest at USD 619.97 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents






